AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

INSPIRATION HEALTHCARE GROUP PLC

Board/Management Information Sep 23, 2020

7711_rns_2020-09-23_d4c834bc-116b-4221-8a49-b38273dd469e.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 7704Z

Inspiration Healthcare Group PLC

23 September 2020

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Appointment of Dr. Peter Reynolds

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, is pleased to announce that it has appointed Dr. Peter Reynolds as the Group's Vice President for Clinical Innovation and Compliance. Peter is a Consultant Neonatologist and Paediatrician based at St. Peter's Hospital, Chertsey, Surrey and has a strong track record in research, quality improvement and teaching. He holds an MB.BS medical degree, a MSc (University of London) in Clinical Paediatrics, and a PhD (Imperial College London) in Immunology. He has also achieved the MRCPCH, MRCGP and DRCOG Royal Colleges exams. 

As a Consultant Neonatologist he specialises in the care of premature and sick babies and the outpatient management of babies and infants. Peter is also the clinical Speciality Neonatal Lead, Neonatal Research Lead, Joint South East Neonatal Network Clinical Lead, and Honorary Senior Lecturer at Royal Holloway University of London. In 2018, he won the "Who Cares Wins" award for Best Neonatal Specialist in the UK.

At Inspiration Healthcare, as a non-Board member he will work closely with the senior management team to drive forward the Company's clinical research, compliance (Quality Assurance and Regulatory Affairs), R&D and Product management and will join the Company on the 12th October 2020.

Dr. Reynolds said 'I am truly delighted to join this growing and ambitious company which is focussed on developing important products to help improve the outcomes of sick and premature babies. I will bring my extensive clinical experience and knowledge of neonatology to help lead clinical product development and future innovations for the Group. This is an exciting challenge for me personally and I look forward to making a real contribution to the success of this dynamic company.'

Neil Campbell, Chief Executive Officer, commented, "We have known Peter for many years and welcome his expertise and experience which will be invaluable as the Company continues to grow and upskill its clinical expertise. He is an extremely well known and recognised figure in our specialist industry having written a wide range of publications and through his teaching and lecturing in the UK as well internationally and we are looking forward to working with him."

Enquiries:

Inspiration Healthcare Group plc

Neil Campbell, Chief Executive Officer

Jon Ballard, Chief Financial Officer
Tel: 01455 840555
Nominated Adviser & Broker

Cenkos Securities plc

Mark Connelly

Stephen Keys

Cameron MacRitchie
Tel: 0207 397 8900
Cadogan PR                                                                                         

Alex Walters

[email protected]
Tel: 07771 713608

About Inspiration Healthcare Group

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in neonatal intensive care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.

The Company has key own brand products that can be used within the first days of life to help premature and sick babies; helping  resuscitation and stabilisation in the first moments of life through to preventing brain damage and both invasive and non-invasive respiratory support in terms of capital equipment and disposable medical devices. Additionally, the Company has its own range of products for maintaining normothermia pre, during and post-surgery.

Since September 2019, the Company has acquired Vio Holdings a designer, manufacturer and supplier of single use respiratory products and sterile medical consumables and S.L.E., a leading designer, manufacturer and global provider of neonatal ventilation products. The Group generates approximately 60% of its revenues from export markets and around two-thirds of its revenues come from its own-branded products. 

With product availability actively promoted to over 75 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the UK and Ireland the Group has direct sales teams selling Group Branded and complementary products from third parties, with an additional range of home healthcare products.  This is supported by Technical Support for planned preventative maintenance and emergency assistance.

The Group operates from various sites in the UK for R&D, Marketing and operations with manufacturing based in Croydon (south London) and Hailsham (East Sussex).  The Group's Head Office is located in Crawley, a short distance from London's Gatwick Airport. Further information on Inspiration Healthcare can be found at www.inspiration-healthcare.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Private Policy.

END

NRAKKBBQQBKDACB

Talk to a Data Expert

Have a question? We'll get back to you promptly.